Neurohormonal Therapy for Congestive Heart Failure

Guidelines for heart failure management have been published by the American College of Cardiology and the American Heart Association in 2001. These guidelines recommend the use of angiotensin-converting enzyme inhibitors and beta blockers to improve the symptoms and prognosis of heart failure. Despi...

Full description

Saved in:
Bibliographic Details
Published in:Current treatment options in cardiovascular medicine 2004-12, Vol.6 (6), p.499-507
Main Authors: Pritchett, Allison M, Mann, Douglas L
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Guidelines for heart failure management have been published by the American College of Cardiology and the American Heart Association in 2001. These guidelines recommend the use of angiotensin-converting enzyme inhibitors and beta blockers to improve the symptoms and prognosis of heart failure. Despite being advocated as the cornerstone of medical management, these agents remain underutilized. Not only are these drugs underutilized, but titration to dosages with proven beneficial effects is lacking. Simply achieving widespread usage of these agents would have a significant impact on heart failure outcomes.
ISSN:1092-8464
1534-3189
DOI:10.1007/s11936-004-0007-6